NCT02194530View on ClinicalTrials.gov

Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

March 30, 2015

Primary Completion Date

July 19, 2016

Study Completion Date

July 19, 2016

Conditions
Peanut Allergy
Trial Locations (1)

10021

Department of Genetic Medicine, Weill Cornell Medicine, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT02194530 - Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy | Biotech Hunter | Biotech Hunter